Published • loading... • Updated
Cigna Drops Employee Coverage of GLP-1 Drugs
Cigna said it is ending coverage as GLP-1 weight-loss drugs face tighter management and higher costs for employers.
Summary by News & Record
4 Articles
4 Articles
Tulsa World+2 Reposted by 2 other sources
Cigna drops employee coverage of GLP-1 drugs
NEW YORK — Health insurer Cigna will stop covering GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound, in its employee health plan effective July 1, according to materials viewed
·Tulsa, United States
Read Full Article
Cigna Ends GLP-1 Coverage for Employees
Health insurer Cigna has announced a major change to its employee health benefits. Beginning July 1, 2026, the company will stop covering GLP-1 weight-loss medications for employees enrolled in its internal health plan. The decision affects popular obesity treatments such as Wegovy and Zepbound, which have gained widespread attention for their effectiveness in helping patients lose weight. The move highlights the growing debate over the long-ter…
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources4
Leaning Left1Leaning Right0Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 33%
C 67%
Factuality
To view factuality data please Upgrade to Premium
